Ampersand Biomedicines funding Ampersand Biomedicines funding profile: $65M total raised. Latest round: Series B. Backed by Lilly. Headquarters: Boston, United States InvestorsLilly Fundraising guidesHe Sold His First Company To Google And Now Raised 19 Million To Simplify Paying PeopleHow to Calculate Your Startup's Break-Even PointHow to Measure Fundraising Success: Metrics That Matter to Founders and Investors More company funding profilesAmphista TherapeuticsAMPIN Energy TransitionAmpersand Browse the company funding database · Browse investors · Fundraising library All companies by funding raisedCompanies page 2San Francisco startupsNew York startupsLondon startupsBoston startupsAustin startupsSeed stage companiesSeries A stage companiesSeries B stage companiesSeries C stage companiesGrowth stage companiesIpo stage companiesStartups funded in 2026
